Regulations.gov document
Presentation from TEVA Pharmacuetical re February 25, 2014 Type C FDA Meeting on…
Other · FDA-2013-P-1641 · posted Mar 5, 2014
Key facts
| Document ID | FDA-2013-P-1641-0004 |
|---|---|
| Title | Presentation from TEVA Pharmacuetical re February 25, 2014 Type C FDA Meeting on Scientific Data on Copaxone’s Complexity and Mode of Action in Consideration of Evidentiary Standards for Follow on Products |
| Document type | Other |
| Subtype | Presentation |
| Agency | FDA |
| Docket | FDA-2013-P-1641 |
| Posted | Mar 5, 2014 |
| Comment period opens | Mar 5, 2014 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: